Harvard Bioscience Statistics
NASDAQ: HBIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
8.13-0.37 (-4.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Harvard Bioscience by the numbers
Harvard Bioscience has a market capitalization of $37.0 million based on 4.55M shares outstanding. With trailing EPS of $-2.31, Harvard Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.5% above its 50-day average and 29.1% above its 200-day average.
Average daily trading volume is 17.87K shares, or about $145,291 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HBIO valuation vs. peer median
| Metric | HBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $37.01M | $47.12M | -21% |
| Avg. volume | 17.87K | 621.84K | -97% |
Peer median across 8 companies: PRPO, RPID, CIRC, BNGO, ASTC, SEER, QTRX, NAUT.
Valuation
- Market cap
- $37.01M
- Forward P/E
- 12.60
- EPS (TTM)
- $-2.31
- Shares outstanding
- 4.55M
Price and trading
- Previous close
- 8.50
- Open
- 8.47
- Day range
- 7.99 – 8.80
- 52-week range
- 3.80 – 9.40
- 52-week change
- +93.18%
- Beta
- —
- Volume
- 17.93K
- Average volume
- 17.87K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 37.01M
- Forward Pe
- 12.60
- Eps
- -2.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.40
- Week52 Low
- 3.80
- Avg Volume
- 17,871.00
- Shares Outstanding
- 4.55M
- Ma50
- 7.49
- Ma200
- 6.30
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -13.51%
- Pct From52w Low
- 113.95%